[30B2-30B2];[30B3-30B3];
A set of isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Initial set of 519 isogenic deletions provides 56% genome coverage.
The current Exelixis collection at the Bloomington Stock Center differs from the original described in FBrf0175003 : a significant number were shown not to carry a deletion and have been removed from the collection; a number of stocks have been lost; a number of additional deletions are included that were generated after publication.
30B2;30B3
PCR amplification tests reveal that the expected deletion is not present in the Bloomington stock. It is likely that the deletion was never present.
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Deletion has not been verified by complementation tests or tests for deleted sequences.